Table 1:
Study Characteristics by disease site
| Alla | Cervix | Vagina | Vulva | p-value | |
|---|---|---|---|---|---|
| Total | 75 | 48 | 13 | 17 | |
| Median age (range), years | 46 (26-75) | 40 (26-69) | 60 (38-69) | 59 (36-75) | <0.001 |
| Ethnicity, n (%) | <0.001 | ||||
| Non-Hispanic White | 41 (54.7) | 16 (33.3) | 11 (84.6) | 16 (94.1) | |
| Hispanic | 23 (30.7) | 23 (47.9) | 1 (7.7) | 0 (0.0) | |
| African American | 8 (10.6) | 6 (12.5) | 1 (7.7) | 1 (5.9) | |
| Asian | 3 (4.0) | 3 (6.2) | 0 (0.0) | 0 (0.0) | |
| HIV status, n (%) | 0.13 | ||||
| Negative | 70 (93.3) | 46 (95.8) | 12 (92.3) | 15 (88.2) | |
| Positive | 1 (1.3) | 0 (0.0) | 1 (7.7) | 0 (0.0) | |
| Unknown | 4 (5.4) | 2 (4.2) | 0 (0.0) | 2 (11.8) | |
| HPV vaccination, n (%) | 0.89 | ||||
| Yes | 1 (1.3) | 1 (2.1) | 0 (0.0) | 0 (0.0) | |
| No | 54 (72.0) | 35 (72.9) | 9 (69.2) | 12 (70.6) | |
| Unknown | 20 (26.7) | 12 (25.0) | 4 (30.8) | 5 (29.4) |
a
: one patient with cervical disease and two patients with vulva disease also presented with vaginal disease